Professional Medical Expertise Company (TADAWUL:9574)
98.00
0.00 (0.00%)
Apr 29, 2026, 1:00 PM AST
TADAWUL:9574 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Net Income | 41.71 | 27.65 | 24.84 | 19.02 | 20.62 | Upgrade
|
| Depreciation & Amortization | 8.62 | 6.63 | 5.45 | 3.07 | 2.37 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.69 | -1.44 | -1.09 | -0 | 0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.84 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 3.32 | 3.8 | 2.79 | 2.39 | 0.44 | Upgrade
|
| Other Operating Activities | 19.93 | 14.46 | 7.99 | 6.23 | 4.2 | Upgrade
|
| Change in Accounts Receivable | -91.28 | -6.51 | -37.55 | -14.57 | -33.12 | Upgrade
|
| Change in Inventory | -9.3 | -33.97 | -40.43 | -25.19 | -13.39 | Upgrade
|
| Change in Accounts Payable | 26.18 | -7.6 | 47.69 | 6.95 | 28.71 | Upgrade
|
| Change in Other Net Operating Assets | 2.38 | -4.91 | -3.82 | -1.82 | 11.14 | Upgrade
|
| Operating Cash Flow | 0.72 | -1.88 | 5.88 | -3.92 | 21.03 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 75.31% | Upgrade
|
| Capital Expenditures | -24.23 | -6.58 | -8.98 | -6.51 | -3.34 | Upgrade
|
| Sale of Property, Plant & Equipment | 8.42 | 3.47 | 2.18 | 0.12 | - | Upgrade
|
| Investing Cash Flow | -15.81 | -3.11 | -6.8 | -6.39 | -3.34 | Upgrade
|
| Short-Term Debt Issued | 242.88 | 221 | 4.66 | 18.79 | 0.63 | Upgrade
|
| Total Debt Issued | 242.88 | 221 | 4.66 | 18.79 | 0.63 | Upgrade
|
| Short-Term Debt Repaid | -211.52 | -189.88 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -2.88 | -1.85 | -1.94 | -0.63 | -0.47 | Upgrade
|
| Total Debt Repaid | -214.4 | -191.73 | -1.94 | -0.63 | -0.47 | Upgrade
|
| Net Debt Issued (Repaid) | 28.48 | 29.27 | 2.72 | 18.16 | 0.16 | Upgrade
|
| Common Dividends Paid | -3.5 | -9.98 | - | -16 | -2.9 | Upgrade
|
| Other Financing Activities | -10.93 | -10.37 | -6.16 | -4.33 | -2.52 | Upgrade
|
| Financing Cash Flow | 14.05 | 8.93 | -3.44 | -2.17 | -5.26 | Upgrade
|
| Net Cash Flow | -1.04 | 3.94 | -4.36 | -12.49 | 12.43 | Upgrade
|
| Free Cash Flow | -23.52 | -8.46 | -3.1 | -10.43 | 17.69 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 78.03% | Upgrade
|
| Free Cash Flow Margin | -5.62% | -2.70% | -1.24% | -5.93% | 13.48% | Upgrade
|
| Free Cash Flow Per Share | -6.72 | -2.42 | -0.89 | -4.67 | 22.93 | Upgrade
|
| Cash Interest Paid | 10.93 | 10.37 | 6.16 | 4.33 | 2.52 | Upgrade
|
| Levered Free Cash Flow | -47.45 | -29.59 | -17.53 | -48.46 | 9.68 | Upgrade
|
| Unlevered Free Cash Flow | -40.19 | -22.83 | -13.38 | -48.4 | 9.68 | Upgrade
|
| Change in Working Capital | -72.02 | -52.98 | -34.11 | -34.63 | -6.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.